Evidence map›Paper›PMID 41334467›Full record

ArticleJugan geon-gang gwa jilbyeong2024

[Introduction to the Second Malaria Re-elimination Action Plan (2024-2028) toward Malaria Eliminatiion by 2030].

Seon-Young Lee, So-Dam Lee, Se-Kyong Oh, Seongwoo Park, Ji-Yeon Lee, Jonghee Kim

Abstract readEnglish Abstract
In one paragraph

Article in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Molecular Surveillance ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seon-Young Lee질병관리청 감염병정책국 인수공통감염병관리과.
So-Dam Lee질병관리청 감염병정책국 인수공통감염병관리과.
Se-Kyong Oh질병관리청 감염병정책국 인수공통감염병관리과.
Seongwoo Park질병관리청 감염병정책국 인수공통감염병관리과.
Ji-Yeon Lee질병관리청 감염병정책국 인수공통감염병관리과.
Jonghee Kim질병관리청 감염병정책국 인수공통감염병관리과.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2019, the Republic of Korea (ROK) developed a national malaria re-elimination action plan as a priority country, designated by the World Health Organization for malaria elimination certification. In the first phase of the National Malaria Re-elimination Action Plan, efforts were made to increase early patient diagnosis and treatment rates. In 2019, the initiative included the introduction of rapid diagnostic kits under insurance coverage and the publication of the "Malaria Treatment Guidelines." Additionally, the introduction of insurance coverage for glucose-6-phosphate dehydrogenase testing in 2020 and the promotion of cluster case monitoring have also been pursued. Domestic malaria cases peaked at 4,142 in 2000, but efforts aligned with the 2019 Action Plan resulted in a decrease to 356 and 274 cases in 2020 and 2021, respectively. However, cases subsequently increased to 382 and 673 by 2022 and 2023, respectively. Consequently, the second phase of the National Malaria Re-elimination Action Plan reflects the achievements and limitations of the first phase, proposing four implementation strategies, and ten key tasks for further advancement.The second phase of ROK's Malaria Re-elimination Action Plan aims to accelerate domestic malaria elimination by 2030 by focusing on disrupting the transmission chain between patients and vectors. These efforts include implementing active surveillance, enhancing patient management, and improving vector control through scientific measures. Collaboration between government ministries, local authorities, and private medical institutions should be reinforced. The plan aims for zero malaria cases by 2028 and seeks to establish a national malaria elimination certification system.

Indexed as

Disease eliminationMalariaStrategies

Identifiers

PMID41334467
PMCPMC12480425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.